Abstract: Many physical therapy practitioners have not adopted telehealth because of practical, regulatory and/or payor/reimbursement complexities. Systems and methods described herein can facilitate the adaptation of telehealth in physical therapy. A unique first virtual physical therapy session for a first patient (at a first location) using a first instance of a physical therapy system can be conducted by a practitioner (at a location) at a time in a first channel. A a unique second virtual physical therapy appointment for a second patient (at a second location) using a second instance of the physical therapy system can be conducted by the practitioner (at the location) at the time in a second channel. The practitioner monitors the first channel and the second channel during the time in order to coach, correct, and/or counsel the first patient and the second patient.

Abstract: A patient can undergo physical therapy to rehabilitate a musculoskeletal condition. The success of the rehabilitation relies in part on whether the patient uses an exercise band with the correct resistance for their condition. In order to select the correct resistance, a controller can instruct the patient to perform a directed movement with an exercise band, receive exercise data from at least one sensor (e.g., a camera, like a front-facing camera, that records the patient, a plurality of sensors on or near the patient's skin, etc.) as the subject performs the directed movement, and calculate a pull force exerted by the patient on the exercise band based on at least a portion of the exercise data. The adequacy of an exercise with the exercise band for the patient is determined based on the pull force can be determined based on the calculated pull force.

Abstract: A patient can undergo physical therapy to rehabilitate a musculoskeletal condition. The success of the rehabilitation relies in part on whether the patient uses an exercise band with the correct resistance for their condition. In order to select the correct resistance, a controller can instruct the patient to perform a directed movement with an exercise band, receive exercise data from at least one sensor (e.g., a camera, like a front-facing camera, that records the patient, a plurality of sensors on or near the patient's skin, etc.) as the subject performs the directed movement, and calculate a pull force exerted by the patient on the exercise band based on at least a portion of the exercise data. The adequacy of an exercise with the exercise band for the patient is determined based on the pull force can be determined based on the calculated pull force.

Abstract: Many physical therapy practitioners have not adopted telehealth because of practical, regulatory and/or payor/reimbursement complexities. Systems and methods described herein can facilitate the adaptation of telehealth in physical therapy. A unique first virtual physical therapy session for a first patient (at a first location) using a first instance of a physical therapy system can be conducted by a practitioner (at a location) at a time in a first channel. A a unique second virtual physical therapy appointment for a second patient (at a second location) using a second instance of the physical therapy system can be conducted by the practitioner (at the location) at the time in a second channel. The practitioner monitors the first channel and the second channel during the time in order to coach, correct, and/or counsel the first patient and the second patient.

Abstract: A patient can undergo physical therapy to rehabilitate a musculoskeletal condition. The success of the rehabilitation relies in part on whether the patient uses an exercise band with the correct resistance for their condition. In order to select the correct resistance, a controller can instruct the patient to perform a directed movement with an exercise band, receive exercise data from at least one sensor (e.g., a camera, like a front-facing camera, that records the patient, a plurality of sensors on or near the patient's skin, etc.) as the subject performs the directed movement, and calculate a pull force exerted by the patient on the exercise band based on at least a portion of the exercise data. The adequacy of an exercise with the exercise band for the patient is determined based on the pull force can be determined based on the calculated pull force.

Abstract: A method for providing a fractured bone with a bone cerclage according to an exemplary aspect of the present disclosure includes, among other things, wrapping a folded piece of suture around a bone at least once, and securing the suture to the bone.

Abstract: A method for providing a fractured bone with a bone cerclage according to an exemplary aspect of the present disclosure includes, among other things, wrapping a folded piece of suture around a bone at least once, and securing the suture to the bone.

Abstract: A humeral prosthesis includes a stem component with a lateral stem body and a head component joined by an inclination component or block. The stem component and the inclination component are provided with openings/holes/fenestrations/eyelets that allow attachment of soft tissue (and optional fracture repair). A first plurality of suture holes are provided to the lateral stem body and a second plurality of suture holes are provided on the medial aspect of the inclination block. These suture holes are intended for subscapularis or lesser tuberosity reattachments. Inclination angle, radial offset, and version are adjustable and are separately and independently set and fixed.

Abstract: A tensioning construct with a tape securely attached to a locking button provided with a securing mechanism in the form of a trap door-like mechanism. The tape is looped so that the looped portion of the tape is passed around a feature of the button to allow easy sliding of the tape. One free end of the tape is fed through the securing mechanism (trap door) of the locking button while the other free end is fixed to the locking button. The button self-engages without the need of a locking instrument, to lock the tape as it is tightened during the cerclage repair. The tensioning construct may be provided as a pre-assembled construct.

Abstract: A humeral prosthesis includes a stem component and a head component joined by an inclination component or block. The stem component and the inclination component are provided with openings/holes/fenestrations/eyelets that allow attachment of soft tissue (and optional fracture repair). A first plurality of suture holes are provided to the lateral stem body and a second plurality of suture holes are provided on the medial aspect of the inclination block. These suture holes are intended for subscapularis or lesser tuberosity reattachments. Inclination angle, radial offset, and version are adjustable and are separately and independently set and fixed.

Abstract: The present invention relates to the use of protein expression profiles of sPLA2 isoforms with clinical relevance to osteoarthritis (OA). In particular, the invention provides methods for diagnosing OA or determining risk factors for development of OA based on expression of sPLA2-IIA.

Abstract: The present invention relates to the identification and use of protein expression profiles with clinical relevance to osteoarthritis. In particular, the invention provides the identity of marker proteins whose expressions are correlated with OA, and/or OA progression. Methods and kits are described for using these protein expression profiles in the study and/or diagnosis of OA, in the determination of the degree of advancement of OA, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that modulate expression of these proteins or nucleic acid molecules encoding these proteins, in particular for the development of disease-modifying OA agents.

Abstract: The present invention relates to the identification and use of protein expression profiles with clinical relevance to osteoarthritis (OA). In particular, the invention provides the identity of marker proteins whose expressions are correlated with OA, OA subtype, and/or OA progression. Methods and kits are described for using these protein expression profiles in the study and/or diagnosis of OA, in the determination of the degree of advancement of OA, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that modulate expression of these proteins or nucleic acid molecules encoding these proteins, in particular for the development of disease-modifying OA agents.

Abstract: The present invention relates to the use of protein expression profiles of sPLA2 isoforms with clinical relevance to osteoarthritis (OA). In particular, the invention provides methods for diagnosing OA or determining risk factors for development of OA based on expression of sPLA2-IIA.

Abstract: The present invention relates to the identification and use of protein expression profiles with clinical relevance to osteoarthritis (OA). In particular, the invention provides the identity of marker proteins whose expression is correlated with OA and OA progression. Methods and kits are described for using these protein expression profiles in the study and/or diagnosis of OA, in the determination of the degree of advancement of OA, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that modulate expression of these proteins or nucleic acid molecules encoding these proteins, in particular for the development of disease-modifying OA agents.

Abstract: The present invention relates to the identification and use of protein expression profiles with clinical relevance to osteoarthritis (OA). In particular, the invention provides the identity of marker proteins whose expressions are correlated with OA, OA subtype, and/or OA progression. Methods and kits are described for using these protein expression profiles in the study and/or diagnosis of OA, in the determination of the degree of advancement of OA, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that modulate expression of these proteins or nucleic acid molecules encoding these proteins, in particular for the development of disease-modifying OA agents.